N

New Jersey Hematology Oncology Associates | Brick Office

Research site
(Unclaimed)
Location
1608 Route 88 West Suite 250, Brick, New Jersey, United States of America

Site insights

Top conditions

Top treatments

Ruxolitinib
Parsaclisib
Azacitidine
Atezolizumab
Trastuzumab
Ibrutinib
Inavolisib
nivolumab
Alectinib
Decitabine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 18 total trials

A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer

This is a Phase II, randomized, multi-center, multinational, open-label, cross-over study in adult participants with PD-L1-positive NSCLC. Two popula...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Atezolizumab

The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (...

Enrolling
Acute Myeloid Leukemia (AML)
Drug: BP1001 plus decitabine
Drug: BP1001 in combination with Ventoclax plus decitabine
Recently updated

This trial will study two treatment combinations for classical Hodgkin lymphoma (cHL). This trial will find out if these two treatment combinations w...

Active, not recruiting
Hodgkin Lymphoma
Drug: doxorubicin
Drug: vinblastine

The purpose of this study is to determine whether the combination of pevonedistat and azacitidine improves event-free survival (EFS) when compared wi...

Active, not recruiting
Leukemia, Myeloid, Acute
Leukemia, Myelomonocytic, Chronic
Drug: Pevonedistat
Drug: Azacitidine

The purpose of the study is to compare the efficacy and safety of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib...

Active, not recruiting
Post Polycythemia Vera Myelofibrosis
Myelofibrosis
Drug: parsaclisib
Drug: placebo

The purpose of the study is to compare the efficacy of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in particip...

Active, not recruiting
Post Polycythemia Vera Myelofibrosis
Myelofibrosis
Drug: parsaclisib
Drug: placebo

Trial sponsors

Incyte logo
BeiGene logo
B
Genentech logo
Halozyme logo
H
H
MacroGenics logo
O
Roche logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems